Patents by Inventor Kiranmai Durvasula

Kiranmai Durvasula has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190055509
    Abstract: Embodiments of the present disclosure provide a multistage procedure for treatment of biological samples (e.g., living cells with membranes, and the like) with a substance (e.g., a drug, DNA, RNA, plasmids, and other biomolecules or materials) to achieve more efficacious intracellular delivery and transfection.
    Type: Application
    Filed: July 5, 2018
    Publication date: February 21, 2019
    Inventors: John Mark Meacham, Kiranmai Durvasula, Andrei G. Fedorov, Fahrettin Levent Degertekin, Akash Mehta
  • Publication number: 20170292106
    Abstract: Embodiments of the present disclosure provide a multistage procedure for treatment of biological samples (e.g., living cells with membranes, and the like) with a substance (e.g., a drug, DNA, RNA, plasmids, and other biomolecules or materials) to achieve more efficacious intracellular delivery and transfection.
    Type: Application
    Filed: June 21, 2017
    Publication date: October 12, 2017
    Inventors: John Mark Meacham, Kiranmai Durvasula, Andrei G. Fedorov, Fahrettin Levent Degertekin, Akash Mehta
  • Patent number: 9725709
    Abstract: Embodiments of the present disclosure provide a multistage procedure for treatment of biological samples (e.g., living cells with membranes, and the like) with a substance (e.g., a drug, DNA, RNA, plasmids, and other biomolecules or materials) to achieve more efficacious intracellular delivery and transfection.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: August 8, 2017
    Assignee: OPENCELL TECHNOLOGIES, INC.
    Inventors: John Mark Meacham, Kiranmai Durvasula, Andrei G. Fedorov, Fahrettin Levent Degertekin, Akash Mehta